District Court Did Not Rely on Flawed Obvious to Try Rational
In Teva Pharmaceuticals USA, Inc., v. Sandoz Inc., [2017-1575] (October 12, 2018), the Federal Circuit affirmed the district court decision invalidating for obviousness all asserted claims of patents directed to COPAXONE® 40mg/mL, a product marketed for treatment of patients with relapsing forms of … Continue reading District Court Did Not Rely on Flawed Obvious to Try Rational
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed